<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>22</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Clinical Features of Patients with Esophageal and Second Primary Cancers</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>9831</FirstPage>
			<LastPage>9834</LastPage>
			<ELocationID EIdType="pii">30186</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; The prevalence of esophageal cancer (EC) with second primary cancers (SPC) is increasingworldwide. This study was aimed to understand the clinical features of EC patients with SPC in the Taiwanesepopulation. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Clinical and laboratory data for 180 EC patients with or without SPC werecollected between January 2009 and December 2013. Information on treatment approaches, location of SPCsand ABO blood type were also collected and stratified. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: The most common SPC in EC patients washypopharyngeal cancer, followed by laryngeal cancer and hepatocellular carcinoma in our study. Malignanciesof colon, prostate and lung were also found. There was a significant higher portion of blood type A in the ECpatients with SPC compared with those without (42.4% vs 19.5%, P=0.006). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: The frequency andSPC site distribution and blood type A should be considered in clinical evaluation of EC patients with a highrisk of developing SPC in the Taiwanese population.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Esophageal Cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">second primary cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">blood type</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Taiwan</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30186_1308953284e807d74639c8a68cc1aedd.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
